Roadshow
BRAXX Esophageal Applicator
"BRAXX" Esophageal Brachytherapy Applicator
Esophageal cancer brachytherapy applicator consists of multiple independently controlled balloons.
It is designed to fit most commercially available after-loading platform.
FDA 510(k) cleared & TFDA approval.
Radiotherapy is one of the main treatments for esophageal cancer. Current radiotherapy skills are limited to the thoracic organ damages, and it is not easy to cure with the corresponding dose. Brachytherapy is a way to give local high-dose radiotherapy, but it also accompanied by severe side effects and sophisticated operations. The "BRAXX" Esophageal applicator is mainly used for the brachytherapy of esophageal cancer. It is composed of ultra-thin diameter catheter and sets of compliant balloons. It can be done in hospital clinic and improve precise positioning of radioactive sources, elevating efficiency and reducing side effects.
The applicator has obtained TFDA, PMDA and US FDA 510k approvals. It is the first domestically-made innovative medical device covered by Taiwan NHI in recent years.
- Established 2016
- Company BRAXX Biotech Co., Ltd.
- Email service@braxx.com.tw
- Address 6F.-3, No. 31-1, Sec. 2, Xinsheng N. Rd., Zhongshan Dist., Taipei City 104, Taiwan